PMID: 11926576Apr 3, 2002Paper

Treatment of Helicobacter pylori infection. Indications and regimens: an update

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
F BazzoliR M Zagari

Abstract

The management of Helicobacter pylori infection is still surrounded by controversy and uncertainties. Indications and correct application of current regimens for Helicobacter pylori infection are still considered a matter of debate. Regarding indications, only peptic ulcer and mucosa associated lymphoid tissue lymphoma are considered clear indications for treatment. In other conditions, such as atrophic gastritis, post gastric cancer resection, first-degree relatives of gastric cancer patients, dyspeptic patients, patients with gastro-oesophageal reflux disease and non-steroidal anti-inflammatory drug users, the value of Helicobacter pylori eradication is still controversial. The regimens for first-line and second-line treatment of Helicobacter pylori infection have been recommended by the Maastricht 2 Consensus Report. Although all the treatments are considered to be effective, physicians still do not agree on what first-line regimen should be used. Furthermore, a consensus on the duration of the antibiotic treatment is still lacking, although Maastricht guidelines for treatment of Helicobacter pylori infection recommend a one-week therapy. Also regimens, as a third-line treatment, and methods to improve compliance and clinica...Continue Reading

References

Aug 5, 1995·Lancet·I L BealesJ Calam
Jun 17, 1995·Lancet·E J KuipersS G Meuwissen
Jul 1, 1996·Journal of Gastroenterology and Hepatology·G M ForbesB J Collins
Jan 1, 1996·Scandinavian Journal of Gastroenterology. Supplement·P Unge, A Berstad
Dec 1, 1996·Alimentary Pharmacology & Therapeutics·A W HarrisJ J Misiewicz
Dec 12, 1997·Gastroenterology·D Y Graham
Mar 1, 1996·Helicobacter·R W van der HulstG N Tytgat
Oct 13, 1998·Alimentary Pharmacology & Therapeutics·G A PipkinJ R Wood
Dec 24, 1998·The New England Journal of Medicine·K McCollT Hilditch
Apr 24, 1999·Alimentary Pharmacology & Therapeutics·P M NevilleP Moayyedi
Jun 26, 1999·Alimentary Pharmacology & Therapeutics·R J LaheijA L Verbeek
Aug 13, 1999·European Journal of Gastroenterology & Hepatology·A G MeiningM Stolte
Sep 30, 1999·European Journal of Gastroenterology & Hepatology·P Malfertheiner
Oct 8, 1999·The New England Journal of Medicine·N J TalleyM B Fennerty
Nov 24, 1999·European Journal of Gastroenterology & Hepatology·P MoayyediA T Axon

❮ Previous
Next ❯

Citations

Apr 30, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C Scarpignato
Jul 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A ZulloS Morini
Nov 19, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F MarchettiA Ventura
Dec 17, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C GambaroV Savarino
Apr 6, 2011·Antimicrobial Agents and Chemotherapy·David J McGeeTraci L Testerman
Apr 28, 2005·Chemotherapy·Carmelo Scarpignato, Iva Pelosini
May 16, 2006·Digestive Diseases·Carmelo ScarpignatoFrancesco Di Mario
May 6, 2014·International Journal of Pharmaceutics·Adeola O Adebisi, Barbara R Conway
Nov 8, 2011·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Mohammadreza SeyyedmajidiMohammadreza Zali
Jul 4, 2007·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M CaselliUNKNOWN Working Group of the Cervia II Meeting
Mar 19, 2003·Alimentary Pharmacology & Therapeutics·A ZulloS Morini
May 17, 2006·Alimentary Pharmacology & Therapeutics·C Scarpignato, I Pelosini
Dec 17, 2014·The Journal of Pharmacy and Pharmacology·Adeola O AdebisiBarbara R Conway
Oct 6, 2004·Annals of Emergency Medicine·Adi LeibaEhud Grossman
Jun 26, 2013·Journal of Microencapsulation·Adeola O Adebisi, Barbara R Conway
Jul 8, 2015·Therapeutic Delivery·Adeola O Adebisi, Barbara R Conway
Feb 1, 2005·World Journal of Gastroenterology : WJG·Selim AydemirUgur Yilmaz
Feb 3, 2009·European Journal of Gastroenterology & Hepatology·Giovanni MaconiGabriele Bianchi Porro
May 7, 2008·Drugs·Vandana BoparaiGeorge Triadafilopoulos
Sep 28, 2007·Drugs & Aging·Angelo ZulloSergio Morini
Apr 18, 2018·BMC Gastroenterology·Shafika AssaadChristy Costanian
May 20, 2017·World Journal of Gastroenterology : WJG·Nazlı ArslanEbru Demiray-Gürbüz
Jan 6, 2011·Southern Medical Journal·Isilay NadirOrhan Sezgin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Alimentary Pharmacology & Therapeutics
P MalfertheinerEuropean Helicobacter Pylori Study Group (EHPSG)
Infectious Disease Clinics of North America
Maria Joyce, Christopher W Woods
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
S VigneriV Savarino
© 2022 Meta ULC. All rights reserved